You have access
Differential Impact of Fosaprepitant on Infusion Site Adverse Events Between Cisplatin- and Anthracycline-based Chemotherapy Regimens
TAKEO FUJII, NAOKI NISHIMURA, KEVIN Y. URAYAMA, HISAKO KANAI, HIROMASA ISHIMARU, JUNKO KAWANO, OSAMU TAKAHASHI, HIDEKO YAMAUCHI and TERUO YAMAUCHI
Anticancer Research January 2015, 35 (1) 379-383;